Hackner C, Detsch O, Schneider G, Jelen-Esselborn S, Kochs E
Klinik für Anaesthesiologie, Technische Universität München, Klinikum rechts der Isar, Ismaningerstr 22, D-81675 Munich, Germany.
Br J Anaesth. 2003 Oct;91(4):580-2. doi: 10.1093/bja/aeg223.
We compared recovery from high-dose propofol/low-dose remifentanil ('propofol-pronounced') compared with high-dose remifentanil/low-dose propofol ('remifentanil-pronounced') anaesthesia.
Adult patients having panendoscopy, microlaryngoscopy, or tonsillectomy were randomly assigned to receive either propofol-pronounced (propofol 100 microg x kg(-1) min(-1); remifentanil 0.15 microg x kg(-1) min(-1)) or remifentanil-pronounced (propofol 50 microg x kg(-1) min(-1); remifentanil 0.45 microg x kg(-1) min(-1)) anaesthesia. In both groups, the procedure was started with remifentanil 0.4 microg x kg(-1), propofol 2 mg x kg(-1), and mivacurium 0.2 mg x kg(-1). Cardiovascular measurements and EEG bispectral index (BIS) were recorded. To maintain comparable anaesthetic depth, additional propofol (0.5 mg x kg(-1)) was given if BIS values were greater than 55 and remifentanil (0.4 microg x kg(-1)) if heart rate or arterial pressure was greater than 110% of pre-anaesthetic values.
Patient and surgical characteristics, cardiovascular measurements, and BIS values were similar in both groups. There were no differences in recovery times between the groups (time to extubation: 12.7 (4.5) vs 12.0 (3.6) min, readiness for transfer to the recovery ward: 14.4 (4.4) vs. 13.7 (3.6) min, mean (SD)).
In patients having short painful surgery, less propofol does not give faster recovery as long as the same anaesthetic level (as indicated by BIS and clinical signs) is maintained by more remifentanil. However, recovery times were less variable following remifentanil-pronounced anaesthesia suggesting a more predictable recovery.
我们比较了高剂量丙泊酚/低剂量瑞芬太尼(“丙泊酚主导”)与高剂量瑞芬太尼/低剂量丙泊酚(“瑞芬太尼主导”)麻醉后的恢复情况。
将接受全身内镜检查、显微喉镜检查或扁桃体切除术的成年患者随机分配,分别接受丙泊酚主导(丙泊酚100微克·千克⁻¹·分钟⁻¹;瑞芬太尼0.15微克·千克⁻¹·分钟⁻¹)或瑞芬太尼主导(丙泊酚50微克·千克⁻¹·分钟⁻¹;瑞芬太尼0.45微克·千克⁻¹·分钟⁻¹)麻醉。两组均以瑞芬太尼0.4微克·千克⁻¹、丙泊酚2毫克·千克⁻¹和米库氯铵0.2毫克·千克⁻¹开始手术。记录心血管测量数据和脑电图双谱指数(BIS)。为维持可比的麻醉深度,若BIS值大于55,则追加丙泊酚(0.5毫克·千克⁻¹);若心率或动脉压大于麻醉前值的110%,则追加瑞芬太尼(0.4微克·千克⁻¹)。
两组患者的患者和手术特征、心血管测量数据及BIS值相似。两组之间的恢复时间无差异(拔管时间:12.7(4.5)分钟对12.0(3.6)分钟,准备转至恢复病房时间:14.4(4.4)分钟对13.7(3.6)分钟,均值(标准差))。
在进行短时间疼痛手术的患者中,只要通过更多瑞芬太尼维持相同麻醉水平(由BIS和临床体征表明),较少的丙泊酚并不会带来更快的恢复。然而,瑞芬太尼主导麻醉后的恢复时间变异性较小,提示恢复更可预测。